CARE Ratings Ltd Technical Momentum Shifts Amid Mixed Market Signals

Price Movement and Market Context

On 17 June 2026, CARE Ratings Ltd closed at ₹1,638.90, down 0.66% from the previous close of ₹1,649.80. The stock traded within a range of ₹1,610.10 to ₹1,674.15 during the day, remaining below its 52-week high of ₹1,933.65 but comfortably above the 52-week low of ₹1,393.95. This price action suggests a consolidation phase following recent gains, with investors weighing the stock’s near-term prospects.

Comparatively, CARE Ratings has outperformed the Sensex over the year-to-date period, delivering a 2.38% return against the benchmark’s negative 9.87%. However, over the past month, the stock declined by 9.02%, contrasting with the Sensex’s 2.09% gain, indicating some short-term pressure. Longer-term performance remains robust, with a three-year return of 140.43% significantly surpassing the Sensex’s 21.18%, underscoring the company’s strong growth trajectory in the capital markets sector.

Technical Indicator Analysis

The technical landscape for CARE Ratings is characterised by a blend of bullish and bearish signals across different timeframes and indicators, reflecting a transition phase in momentum.

MACD (Moving Average Convergence Divergence): The weekly MACD remains bullish, signalling positive momentum in the short term. However, the monthly MACD has turned mildly bearish, suggesting that longer-term momentum is weakening and investors should monitor for potential trend reversals.

RSI (Relative Strength Index): Both weekly and monthly RSI indicators currently show no definitive signal, indicating that the stock is neither overbought nor oversold. This neutral RSI reading aligns with the observed price consolidation and suggests a wait-and-watch approach may be prudent.

Bollinger Bands: The stock maintains a bullish stance on both weekly and monthly Bollinger Bands, implying that price volatility remains within an upward trending channel. This technical strength supports the possibility of further upside if confirmed by other indicators.

Moving Averages: Daily moving averages continue to be bullish, reinforcing short-term upward momentum. This is a positive sign for traders looking for entry points, as the stock price remains above key moving average levels.

KST (Know Sure Thing) Indicator: The weekly KST is bullish, consistent with the MACD and moving averages, but the monthly KST is mildly bearish, echoing the caution flagged by the monthly MACD. This divergence between weekly and monthly KST readings highlights the importance of timeframe in technical analysis for CARE Ratings.

Dow Theory: Weekly Dow Theory signals a mildly bullish trend, while the monthly perspective shows no clear trend. This suggests that while short-term price action favours bulls, the longer-term trend remains uncertain.

On-Balance Volume (OBV): Weekly OBV is mildly bearish, indicating that volume trends may not fully support the recent price gains. The monthly OBV shows no trend, further emphasising the need for caution as volume confirmation is lacking.

Mojo Score and Rating Upgrade

CARE Ratings currently holds a Mojo Score of 71.0, reflecting a favourable technical and fundamental outlook. This score has supported an upgrade in the Mojo Grade from Hold to Buy as of 15 June 2026, signalling increased confidence among analysts and investors. The company is classified as a small-cap within the capital markets sector, which often entails higher volatility but also greater growth potential.

The upgrade reflects improved technical momentum despite recent price softness, with the weekly bullish indicators outweighing the mildly bearish monthly signals. Investors should consider this rating in conjunction with the mixed technical signals and broader market conditions.

Long-Term Performance and Valuation Context

Over a 10-year horizon, CARE Ratings has delivered a 65.60% return, trailing the Sensex’s 189.56% gain. However, the company’s shorter and medium-term returns have been impressive, particularly the 140.43% gain over three years and 130.28% over five years, highlighting its strong growth phase in recent years.

This performance underscores the stock’s appeal as a growth-oriented small-cap in the capital markets sector, though investors should remain mindful of valuation levels and sector cyclicality. The current price near ₹1,639 remains below the 52-week high, offering some room for upside if technical momentum sustains.

Technical Outlook and Investor Considerations

CARE Ratings’ technical indicators suggest a cautiously optimistic outlook. The weekly bullish signals from MACD, Bollinger Bands, KST, and moving averages provide a foundation for potential upward movement. However, the mildly bearish monthly MACD and KST, alongside neutral RSI and weak volume confirmation, counsel prudence.

Investors should monitor key support levels near ₹1,610 and resistance around ₹1,675 to gauge momentum shifts. A sustained break above the recent high could confirm a return to stronger bullish trends, while a drop below support may signal further consolidation or correction.

Given the stock’s small-cap status and sector dynamics, volatility is expected, and technical signals should be integrated with fundamental analysis and broader market trends for informed decision-making.

Summary

CARE Ratings Ltd’s technical profile is currently characterised by a transition from bullish to mildly bullish momentum, with weekly indicators generally positive but monthly signals showing caution. The stock’s recent price action and volume trends suggest consolidation, while its Mojo Grade upgrade to Buy reflects growing analyst confidence.

Investors should weigh the mixed technical signals alongside the company’s strong medium-term returns and small-cap growth potential. Monitoring key technical levels and broader market conditions will be essential for navigating the stock’s near-term trajectory.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →